SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 87 filers reported holding SUTRO BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $558,240 | -25.4% | 160,876 | 0.0% | 0.00% | – |
| Q2 2023 | $748,073 | +11.0% | 160,876 | +10.2% | 0.00% | – |
| Q1 2023 | $674,243 | -42.1% | 145,940 | +1.2% | 0.00% | – |
| Q4 2022 | $1,164,708 | +59.8% | 144,147 | +9.9% | 0.00% | – |
| Q3 2022 | $729,000 | +16.6% | 131,205 | +9.5% | 0.00% | – |
| Q2 2022 | $625,000 | -36.5% | 119,783 | +0.1% | 0.00% | – |
| Q1 2022 | $984,000 | -39.7% | 119,667 | +9.2% | 0.00% | – |
| Q4 2021 | $1,631,000 | -20.0% | 109,549 | +1.6% | 0.00% | -100.0% |
| Q3 2021 | $2,038,000 | +5.4% | 107,873 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $1,934,000 | +4.4% | 103,998 | +27.8% | 0.00% | 0.0% |
| Q1 2021 | $1,853,000 | +21.5% | 81,398 | +15.9% | 0.00% | 0.0% |
| Q4 2020 | $1,525,000 | +130.4% | 70,225 | +6.6% | 0.00% | – |
| Q3 2020 | $662,000 | +76.5% | 65,859 | +36.5% | 0.00% | – |
| Q2 2020 | $375,000 | +62.3% | 48,231 | +113.5% | 0.00% | – |
| Q1 2020 | $231,000 | -7.2% | 22,592 | 0.0% | 0.00% | – |
| Q4 2019 | $249,000 | +20.9% | 22,592 | 0.0% | 0.00% | – |
| Q3 2019 | $206,000 | -20.2% | 22,592 | 0.0% | 0.00% | – |
| Q2 2019 | $258,000 | +72.0% | 22,592 | +72.3% | 0.00% | – |
| Q1 2019 | $150,000 | +26.1% | 13,110 | 0.0% | 0.00% | – |
| Q4 2018 | $119,000 | – | 13,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |